Researchers compared trends in the average weekly prescriptions of hydroxychloroquine/chloroquine, azithromycin, and 10 commonly used medications dispensed between February 16 and April 25, 2020 with those dispensed between February 17 and April 27, 2019.
Higher rates of decidual arteriopathy and other maternal vascular malperfusion features are seen in placentas of women with severe acute respiratory syndrome coronavirus 2.
Treatment with remdesivir was associated with a shorter time to recovery in patients hospitalized with coronavirus disease 2019 (COVID-19), according to peer-reviewed data published in the New England Journal of Medicine.
COVID-19 spreads swiftly between people but is not easily caught from contaminated surfaces, according to updated information from the US Centers for Disease Control and Prevention.
There is a lack of evidence supporting the use of dietary supplements for the prevention or treatment of COVID-19, despite what recent news or social media platforms have asserted,
The diagnostic specificity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serologic assays varies, and sensitivity is poor during the first 14 days of symptoms.
Epidemiologic, clinical, microbiologic and antimicrobial resistance (AMR) data on nosocomial superinfections during the coronavirus disease 2019 (COVID-19) pandemic is needed to inform stewardship.
In light of the changes inflicted by the COVID-19 pandemic, the researchers wished to explore the effects of the pandemic on stroke management during the first month of Italy’s lockdown.
Sociodemographic factors associated with the risk for a positive severe acute respiratory syndrome coronavirus 2 test result include deprivation, population density, and ethnicity,
The Society of Gynecologic Oncology published recommendations to guide clinicians through shared decision making with patients about anticancer treatment.
